Functioning in schizophrenia: Recommendations of an expert panel
- PMID: 38964076
- DOI: 10.1016/j.schres.2024.06.050
Functioning in schizophrenia: Recommendations of an expert panel
Abstract
Functioning is a fundamental dimension across all aspects of life, frequently compromised or reduced in individuals with schizophrenia. However, the lack of a commonly agreed definition of functioning in schizophrenia makes it difficult to apply this concept in clinical practice. In this document, we make a detailed analysis of the literature to identify and define functioning and describe how it can be used in clinical practice today. We performed a preliminary literature search in the MEDLINE database (via PubMed) for articles discussing functioning in schizophrenia. The articles retrieved were then read and discussed by a panel of psychiatrists specialising in schizophrenia. The conclusions reached in this meeting formed the basis for a new exhaustive literature search for the purpose of synthesising the evidence published in the past 5 years. In this article, we show the importance a comprehensive, modern, homogeneous definition of functioning in schizophrenia, propose a definition of functioning, and put forward a series of recommendations for assessing functioning in clinical practice. We also review current unmet needs and highlight the need for a standardised tool for evaluating functioning.
Keywords: Functioning; Occupational performance; Scales; Schizophrenia.
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest IC has received in the last five years fees and honoraria in terms of registrations for congresses, participation in conferences and working groups from Otsuka-Lunbeck, Janssen, Angelini, Casen Recordati and Okedi. DF has been a consultant and/or has received fees from Angelini, Casen-Recordati, Janssen, Lundbeck, and Otsuka, and has received grant support from Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation), Fundación Alicia Koplowitz, and Fundación La Caixa. MPGP has been a consultant to and/or has received honoraria/grants from Alter, Angelini, Cassen-Recordati, Janssen-Cilag, Idorsia, Lundbeck, Otsuka, and SAGE Therapeutics. JMO has received research funding from Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation), ACIS (Agencia del Conocimiento en Salud de Galicia), Xunta de Galicia, Plan Nacional de Drogas (Spanish Ministry of Science and Innovation). He has also received fees as a consultant and/or speaker from: Janssen, Lundbeck, Otsuka, Adamed, Esteve, Oryzon Genomics, Angelini, Casan Recordati, and Rovi. P. Sierra has received fees or funding from Lundbeck, Janssen, Alter, Servier, Angelini and Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation). P. Sánchez has received honoraria as a board advisor from Rovi, Janssen and Lundbeck. He has also been paid by Janssen and Rovi as honoraria for his contributions in medical education.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous